Erratum: Department of Error (The Lancet (2017) 390(10104) (1807–1810), (S0140673617326028), (10.1016/S0140-6736(17)32602-8));Foundation for a smoke-free world

The Lancet

Volumn 390, Issue 10104, 2017, Pages 1807-1810

  Yach, Derek ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; FUNDING; HARM REDUCTION; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MORTALITY RATE; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC RELATIONS; RISK REDUCTION; SMOKING CESSATION; STIGMA; TOBACCO INDUSTRY; VAPING; AGRICULTURE; HEALTH CARE PLANNING; NON PROFIT ORGANIZATION; SMOKING PREVENTION; TOBACCO;

AGRICULTURE; FOUNDATIONS; HARM REDUCTION; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; SMOKING PREVENTION; TOBACCO; TOBACCO INDUSTRY;

EID: 85032988323     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)33254-3     Document Type: Erratum

References (24)

1. WHO. WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies, 2017, World Health Organization, Geneva Published online July 19, 2017. http://www.who.int/tobacco/global_report/en (accessed Sept 9, 2017).
2. Yach, D, Injecting greater urgency into global tobacco control. Tob Control 14 (2005), 145–148.
3. Bollyky, TJ, Templin, T, Cohen, M, Dieleman, JL, Lower-Income countries that face the most rapid shift In noncommunicable disease burden are also the least prepared. Health Aff 36 (2017), 1866–1875.
4. Chaloupka, FJ, Sweanor, D, Warner, KE, Differential Taxes for Differential Risks—Toward Reduced Harm from Nicotine-Yielding Products. N Engl J Med 373 (2015), 594–597.
5. Bold, KW, Rasheed, AS, McCarthy, DE, Jackson, TC, Fiore, MC, Baker, TB, Rates and predictors of renewed quitting after relapse during a one-year follow-up among primary care patients. Ann Behav Med 49 (2015), 128–140.
6. Terry, M, Seffrin, J, Cummings, KM, Erickson, A, Shopland, D, Ending cigarette use by adults in a generation is possible: the views of 120 leaders in tobacco control, 2017, Core Team on Tobacco Control http://www.tobaccoreform.org/wp-content/uploads/2017/03/Executive-Summary-Report-Ending-Cigarette-Use-by-Adults.pdf (accessed Sept 9, 2017).
7. US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014, US Department of Health and Human Services, Rockville, MD https://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf (accessed Sept 9, 2017).
8. Lund, I, Lund, KE, How has the availability of snus influenced cigarette smoking in Norway?. Int J Environ Res Public Health 11 (2014), 11705–11717.
9. Rahman, MA, Hann, N, Wilson, A, Mnatzaganian, G, Worrall-Carter, L, E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One, 10, 2015, e0122544.
10. Hirano, T, Tabuchi, T, Nakahara, R, Kunugita, N, Mochizuki-Kobayashi, Y, Electronic cigarette use and smoking abstinence in Japan: a cross-sectional study of quitting methods. Int J Environ Res Public Health, 14, 2017, 202.
11. Bauld, L, MacKintosh, AM, Eastwood, B, et al. Young people's use of E-cigarettes across the United Kingdom: findings from five Surveys 2015-2017. Int J Environ Res Public Health, 14, 2017, 973.
12. Kozlowski, LT, Warner, KE, Adolescents and e-cigarettes: objects of concern may appear larger than they are. Drug Alcohol Depend 174 (2017), 209–214.
13. WHO. WHO Framework Convention on Tobacco Control, 2003, World Health Organization, Geneva http://www.who.int/tobacco/framework/WHO_FCTC_english.pdf (accessed Sept 9, 2017).
14. Warner, KE, Schroeder, SA, FDA's Innovative Plan to Address the Enormous Toll of Smoking. JAMA, 2017 published online Sept 8. DOI:10.1001/jama.2017.14336.
15. Yach, D, The origins, development, effects, and future of the WHO Framework Convention on Tobacco Control: a personal perspective. Lancet 383 (2014), 1771–1779.
16. Gottlieb, S, Zeller, M, A nicotine-focused framework for public health. N Engl J Med 377 (2017), 1111–1114.
17. US Department of Health and Human Services. Philip Morris Products S.A. Modified Risk Tobacco Product (MRTP) Applications, 2017, US Food & Drug Administration, Lausanne, Switzerland https://www.fda.gov/TobaccoProducts/Labeling/MarketingandAdvertising/ucm546281.htm (accessed Sept 9, 2017).
18. Porter, ME, Kramer, MR, Creating shared value. Harvard Business Review (Boston), Jan–Feb, 2011 (accessed Sept 9, 2017).
19. National Academies of Sciences, Engineering, and Medicine. Exploring Shared Value in Global Health and Safety: Workshop Summary, 2016, The National Academies Press, Washington, DC https://doi.org/10.17226/23501.
20. Kalra, A, Bansal, P, Wilson, D, Lasseter, T, Inside Philip Morris' campaign to subvert the global anti-smoking treaty. http://www.reuters.com/investigates/special-report/pmi-who-fctc/ (accessed July 15, 2017).
21. Fogarty International Center. https://www.fic.nih.gov/About/Staff/Policy-Planning-Evaluation/Documents/fogarty-tobacco-program-review-2013.pdf, 2012 (accessed Sept 9, 2017).
22. Deyton, L, Sharfstein, J, Hamburg, M, Tobacco product regulation: a public health approach. N Engl J Med 362 (2010), 1753–1756.
23. Cohen, JE, Zeller, M, Eissenberg, T, Parascandola, M, et al. Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry. Tob Control 18 (2009), 228–234.
24. WHO. Guidelines for implementation of Article 5.3 of the International tobacco and health research and capacity building program: program review 2002–2012. http://www.who.int/fctc/guidelines/article_5_3.pdf (accessed Sept 9, 2017).